Review article · 2015
Research articlePublished 2 Dec 2019
Practical Statistical Issues in Evaluation of Average Bioequivalence
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
For approval of generic drug products, the United States Food and Drug Administration (FDA) has published several regulatory guidance to assist the sponsors in preparing documents, which provide substantial evidence for demonstration of bioequivalence between a generic (test) product and its innovative (reference) product (e.g., FDA, 1992, 2003) through the conduct of bioavailability and bioequivalence studies. Bioavailability and bioequivalence studies are usually conducted under crossover designs such as a standard 2x2 crossover design or a higher-order crossover design. Under a crossover design, bioequivalence is commonly evaluated using a two one-sided tests procedure (each at a 5% level of significance) or a 90% confidence interval approach. Bioequivalence is claimed if the constructed 90% confidence interval for the geometric mean ratio falls entirely within the bioequivalence limit of (80%, 125%). Statistical methods for bioequivalence evaluation are well established and widely accepted in the pharmaceutical industry since the publication of the FDA guidance in 2003. However, several practical issues are commonly encountered during the review of regulatory submissions of generic drug products. In this article, these issues are described. In addition, some recommendations for possible clarification and/or resolutions are made.
Keywords
Subjects
Mathematics & StatisticsAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Scaled Average Bioequivalence Statistics for the Non-Statistician
Research article · 2011
Statistical Issues in Bioavailability/Bioequivalence Studies
Article · 2019
Methodological and Statistical Issues in Diagnostic Research
Conference abstract
Evaluation of bioequivalence for endogenous molecules; Statistical impact of different basal levels correction procedures
More from this journal
The newest in Journal of Biometrics & Biostatistics.
Article · 29 Dec 2025
Biometrics Enhance EHR Security and Patient Safety
Article · 29 Dec 2025
Biometric and Clinical Data for Enhanced Risk Prediction
Article · 29 Dec 2025
Advanced Statistics for Precision Public Health Innovations
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biometrics & Biostatistics
- SubjectMathematics & Statistics
- BylineArticles whose byline prints “Shein-Chung Chow”
- BylineArticles whose byline prints “Mo Liu”

